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Available online 9 November 2016Background: Iron Overload Cardiomyopathy (IOC) due to repeated transfusions still represents themain cause of
death in Thalassemia major (TM) patients. Because iron overload remains asymptomatic for long time, it is im-
portant to stratify the patients based on the risk of developing IOC before the appearance of clinical signs of
heart failure. The magnetic resonance imaging (MRI) T2* may be useful but it is expensive and its MRI software
has limited availability; conventional echocardiographic parameters, although easy availability, remain normal
until advanced stages of IOC. Tissue Doppler Imaging (TDI) opened a new way to explore systolic and diastolic
function directly or through derived index such as myocardial performance index (MPI) which has a prognostic
value in different cardiomyopathies.
Methods:We enrolled 46 consecutive β-TM patients without clinical signs of heart failure and we tested them
with echocardiography in 2011 and again in 2015. MPI of left and right ventricular lateral wall was calculated
by TDI. All TM patients had a T2* MRI evaluation of the heart in the year before.
Results: Despite the absence of signiﬁcant changes in morphological data at echo and at T2* evaluation, S′waves
of the lateral ventricularwall decreasewhile time passed, MPIworsened during the follow-up period and the de-
rived systolic pulmonary artery systolic pressure (PAPs) increased in 2015 with respect to 2011.
Conclusion: TDI andMPImay reveal very earlymyocardial dysfunction in TMpatients despite a normal T2* value.
Together with PAPs they should be periodically checked in these patients.






Beta-Thalassemia major (TM) is an inherited chronic anaemia: af-
fected patients are today treated lifelong with repeated blood transfu-
sions but that therapy causes chronic tissue iron overload requiring
intensive treatment with chelating agents [1]. Direct iron-related injury
is responsible for different kinds of cardiovascular abnormalities, in-
cluding progressive worsening of diastolic and systolic ventricular func-
tion, increased arterial stiffness and pulmonary hypertension [2,3].
Despite the improvement in survival, Iron Overload Cardiomyopathy
(IOC) is still the main cause of death in thalassemia major (TM) pa-
tients: themain problem in the care of this illness is that once reduction
in systolic function is observed with conventional echocardiography,
patients are already in a late stage of the inﬁltrative cardiomyopathy.
Therefore, it is important to discover signs of the disease while theuigi Gonzaga Hospital, Regione
land Ltd. This is an open access articlcardiomyopathy is still reversible. The most important advancement
in this ﬁeld has been T2* magnetic resonance imaging (MRI) assess-
ment, which has been used since 2000s: it is a non-invasive method
for imaging the iron accumulation in vital organs such as the heart,
liver, pancreas, and pituitary gland [4]. The impact of non-invasive tech-
niques for the assessment of cardiac and hepatic siderosis before the ap-
pearance of clinical symptoms is well known [5–8]: T2* evaluation is
able to early recognize patients with iron overload and it has gained a
critical importance in the management of these patients, but in clinical
practice echocardiography provides a bedside faster and cheaper tech-
nique to study the heart function.
In the last years some studies reported interesting results about the
utility of Tissue Doppler Imaging (TDI) for the echocardiographic evalu-
ation of patients with beta-thalassemia major, either directly either
with derived index as the myocardial performance index (MPI)
[9–11]. These echocardiographic evaluations could be useful for early
detection of regional myocardial dysfunction before the occurrence of
abnormal indices of global ventricular function andmay be applied dur-
ing clinical follow-up of these patients, especially in the period of timee under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Characteristics of study population at baseline and after 4 years.
2011 2015 p-Value
Age (years) 31,3 ± 6 36,1 ± 6,6
Sex (M/F) 29/17 29/17
Weight (kg) 58,7 ± 10,6 59,7 ± 10,2 NS
Height (m) 1,62 ± 0,07 1,62 ± 0,07 NS
BSA (m2) 1,62 ± 0,16 1,62 ± 0,16 NS
HR (bpm) 84,6 ± 13 79,8 ± 18 NS
SBP (mmHg) 114 ± 17 112 ± 15 NS
Ferritin (ng/ml)† 1596 ± 1593 1472 ± 1178 NS
Hemoglobin (g/dl)† 11 ± 0,5 10.3 ± 0.5 b0,0001
Estimated value of hemoglobin
in the echo's day (g/dl)
11,5 ± 1,1 11,3 ± 1.1 NS
Splenectomy (YES/NO) 30/16 30/16
Iron input (mg/kg/die)† 0,32 ± 0,07 0,38 ± 0.08 0,0002
Chelators:
DFO 8 11
DFO + DFP 6 7
DFP 13 10
DFX 19 18
Compliance (%) 97,2 ± 5,3 88,5 ± 13,3 0,0002
MRI-T2* of the heart† 37.7 ± 11 41 ± 15,7 NS
LIC by SQUID (mcg/g)† 1229 ± 1027 1476 ± 777 0,001
†=average of the previous year, BSA=body surface area, HR=heart rate, SBP= systolic
blood pressure, DFO= deferoxamine, DFP = deferiprone, DFX= deferasirox, LIC = liver
iron concentration, SQUID = Superconducting Quantum Interference Device, MRI =
Magnetic resonance imaging.
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graphic data at baseline and after 4-years follow-up to look for changes
especially concerning TDI and MPI.
2. Methods
From January to October 2011 we prospectively examined with
echocardiography 46 consecutive patients with beta-thalassemia
major (TM) on regular blood transfusion and iron chelation. Inclusion
criteria were: a recent Biosusceptometry SQUID (Superconducting
Quantum Interference Device) to quantify liver iron concentration
(LIC); cardiac iron assessment by MRI T2* technique in the previous
year. Exclusion criteria were: clinical signs of heart failure, valvular
heart disease, pulmonary hypertension, arrhythmias, left ventricular
ejection fraction (LVEF) b55%, ongoing pregnancy, age b 18 years or his-
tory of coronary artery disease. After four years, from February to June
2015 we repeated the exams in the same patients to compare data.
The study protocol was approved by the local ethics committee, and
all patients provided informed consent before participation. The study
was conducted in compliance with the Declaration of Helsinki.
Transthoracic echocardiography was performed 4–9 days after
blood transfusion to ensure hemodynamic stability, using an Aloka
Prosound Alfa 10 ultrasound system (2,5–3,5MHz), by two expert phy-
sicians that were blinded to clinical information about patients until the
end of the study. Cardiac cycleswere stored in a digital format. Chamber
dimensions were determined by standard procedures [12] and valve
ﬂow Doppler and TDI were recorded in the apical 4-chamber view ac-
cording to the guideline [13]. The systolic (S′), early (E′) and late (A′) di-
astolic peak velocities of TDI were assessed on three beats at septal and
lateral mitral origin and at lateral tricuspid origin, and expressed as a
mean. MPI was derived, both for left and right ventricle, from the mea-
surement of intervals registered with TDI [14].
Pulmonary arterial systolic pressure (PAPs) was derived from the
tricuspid regurgitation velocity and an estimate of the right atrial pres-
sure based on the dimension of inferior vena cava [15–16]. For all the
measurements, intervals from 3 consecutive cardiac cycles were stored
and averaged [13]. A repeat MRI was performed in 2015 before echo.
Compliance with each chelator (deferoxamine, deferasirox,
deferiprone) was assessed by interviewing each patient at the transfu-
sion visits, evaluating the signs of deferoxamine infusion at the infusion
sites, and calculating the ratio prescribed chelation/pharmacy dispens-
ing. For deferoxamine, compliance was also evaluated by number of in-
fusions recorded by the electronic infusion pump. For patients on
combination therapy, we considered as compliance the inferior be-
tween those with each of the two chelators.
2.1. Statistical analysis
All data were analyzed using the SPSS version 20.0 (IBM) and
Statistica version 6.0 (Statasoft) statistical package. Categorical data
are presented as frequency and percentage (%). Continuous variables
were presented as mean± standard deviation (SD), median, minimum
and maximums. The comparisons among groups were made by un-
paired Student t-test or Fisher's exact test for continuous variables
with normal distribution, Mann–Whitney U tests for continuous vari-
ables with non-normal distribution and a Chi-squared test for categori-
cal variables. Correlations of T2* MRI with LVEF, serum ferritin levels,
and ages of patients were performed using the Pearson correlation
test. A two-tailed P value b0.05 was considered statistically signiﬁcant.
3. Results
The characteristics of patients in 2011 and in 2015 are summarized
in Table 1. In all patients echocardiographic measurements were fully
assessable. Although time passed, patients' weight and body surface
area didn't change. In 2015 only 2 patients had cardiac iron overloadat MRI versus 8 patients in 2011. Only 1 patient worsened from a
good value to a pathological one. Globally, cardiac iron overload
remained stable over time (37.7 ± 11 ms vs 41.0 ± 15.7 ms, p =
0.23) and substantially normal (i.e. a T2* N 20 ms), while SQUID re-
vealed a worsening in hepatic value. Three patients (6.5%) had diabetes
mellitus, while 9 (19.6%) had thyroid diseases. No patient had arterial
hypertension. Five patients (11%) had dyslipidaemia.
Echo values are listed in Table 2. Morphological data are in normal
ranges, without signiﬁcant changes.
As regards systolic function EF is normal despite the left S′-waves by
TDI are lightly but signiﬁcantly reduced respect to the 2011 data
(10.9 ± 2.73 cm/s vs 9.7 ± 2.32 cm/s, p= 0.02).
Interestingly MPI increased from 2011 to 2015 for left ventricle
(0.52 ± 0.16 vs 0.65 ± 0.23 in LV, p b 0.003) and shows a similar
trend as regards right ventricle (0.41 ± 0.16 vs 0.44 ± 0.17 in RV,
p = 0.48). Regarding diastolic function there are no signiﬁcant
differences.
PAPs mean value was normal in 2011 and remained normal in 2015
but it increase (from 24.38 ± 3 mmHg to 27.7 ± 5.2 mmHg) due to an
increase in tricuspid regurgitation jet velocity (TRV) from 2.16 ±
0.16 m/s to 2.38 ± 0.3 m/s (p b 0.0001). No differences in TRV were
found between splenectomised and non-splenectomised patients
(2.28 ± 0.32 m/s vs 2.41 ± 0.28 m/s).
No correlations were found between MPI with iron related parame-
ters (leftMPI 0.66±0.24 in patientswith T2* ≤ 20msand 0.62±0.21 in
patients with T2* N 20 ms, p = 0,82). Despite the little number of pa-
tients we performed a univariate analysis to check differences between
chelating regimens but no signiﬁcance emerged. An interesting associa-
tion was noted when comparing the mean value of S′ wave in the left
ventricle between patients with high (≥0.55 ms) and low (b0.55 ms)
MPI index (8.80 ± 2.12 cm/s vs 10.32 ± 2.3 cm/s, p= 0.03, see Fig. 1).
4. Discussion
Themain ﬁndings of our study are: 1. Left longitudinal systolic func-
tionmeasuredwith TDI (S′waves of the lateral ventricular wall) has de-
creased over time; 2. The MPI index worsened during the follow-up
period, irrespective of the MRI T2* value.
We started from the well diffused pulsed TDI, a simple and useful
method of assessing ventricular longitudinal function. It has been
Table 2
Comparison of echocardiographic data at baseline and after 4 years.
2011 2015 p-Value
LV mass (g/m2) 77,6 ± 16,3 84,51 ± 19,7 NS
LA area (cm2) 19,8 ± 3 20 ± 3,7 NS
Indexed LVEDD (mm/m2) 29,7 ± 3 22,2 ± 3 NS
IVS (mm) 8,1 ± 1 8,4 ± 1,4 NS
LVPW (mm) 7,8 ± 0,8 8,7 ± 1,1 0,0002
RA area (cm2) 16,4 ± 3 16,1 ± 3,3 NS
E mitral (m/s) 0,76 ± 0,15 0,87 ± 0,2 0,01
A mitral (m/s) 0,51 ± 0,12 0,61 ± 0,16 0,003
E/A mitral 1,55 ± 0,41 1,48 ± 0,46 NS
DecT (msec) 177 ± 29 182 ± 35 NS
E/E′ LV 4,3 ± 0,98 4,8 ± 1,35 NS
LVEF (%) 59,98 ± 2,7 61,5 ± 2,8 NS
S′ septal (cm/s) 9 ± 1,6 9,3 ± 1,2 NS
S′ LV (cm/s) 10.9 ± 2,7 9,7 ± 2,3 0,02
FAC RV (%) 50,2 ± 5,9 48,2 ± 7,7 NS
S′ RV 14 ± 2,4 14,9 ± 2,6 NS
TAPSE (mm) 23,9 ± 3 24,1 ± 3,5 NS
Left MPI 0.52 ± 0.16 0,65 ± 0,23 b0,003
Right MPI 0.41 ± 0.16 0,44 ± 0,17 0,48
TRV (m/s) 2.16 ± 0.16 2,38 ± 0,3 0,0001
PAPs (mmHg) 24.38 ± 3 27,73 ± 5,2 0,0005
LA= left atrium; RA= right atrium; LV= left ventricle; RV= right ventricle; EDD=end
diastolic diameter; IVS= interventricular septum; PW=posterior wall; FAC= fractional
area change; EF= ejection fraction; DecT= deceleration time of mitral E wave; TAPSE=
tricuspidal annulus plain systolic excursion; MPI = myocardial performance index; TRV
= tricuspidal jet velocity; PAPs = systolic pulmonary artery pressure.
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cardiomyopathy of thalassemic patients [9,10,17]. Different studies re-
ported abnormal value of tissue Doppler waves, especially reduced S′
waves in TM patients matched to the healthy controls [18]; also in pa-
tients with low cardiac iron at MRI, a stress test may establish the fact
of the reduced S′wave's response for exercising, proving this parameter
as a possible initial sign of ventricular dysfunction [11]. As it was previ-
ously described for other diseases, early abnormalities of cardiac func-
tion due to iron overloading ﬁrst of all may involve longitudinal
systolic function [19,20]. In our study S′ waves have been reduced
with time despite the normal global systolic function, and this fact
may reﬂect underlying iron damage to longitudinal ﬁbres in spite of
good chelation and low deposition of iron into cardiac tissue at theFig. 1. Negative relation of S′ waves of the Left Ventricle (measured with Tissue Dtime of the last MRI investigation [19,20]. In clinical practice S′ waves
of the right ventricular wall were widely used in all kinds of patients
to assess the right ventricular function; we suppose that the similar ex-
planation might be made for the left ventricle in TM patients.
MPI is a powerful index for the evaluation of both systolic and dia-
stolic functions at the same time [21]. It represents a sensitive indicator
for heart failure that also provides prognostic information in several dif-
ferent pathologies, as dilated cardiomyopathy, anthracycline toxicity,
myocardial infarction and cardiac amyloidosis [14]. It is minimally af-
fected by preload, and it is also independent from ventricular geometry,
heart rate and blood pressure. A previous study reported higher MPI in
TM children and in thalassemia intermedia patients, suggesting that
MPI obtained by TDI may be an adjunctive parameter to conventional
echocardiography for detecting early myocardial damage [22,23]. MPI
is easy to obtain with TDI and in our study it was always assessable.
Probably according to the fact that our patient group showedhigh and
normal values of MRI T2*, indicating absence of cardiac iron overloading,
we were not able to show a linear relation between MPI and T2* value
that could be useful to distinguish among patients with a major risk of
having a cardiac overload. Furthermore, paying attention to the fact that
ferritin levels, T2* levels and haemoglobin remained the same in 2011
and 2015 we suggest that the increase in MPI or in systolic PAPs might
be attributed to a subtle and very earlymyocardial dysfunction not direct-
ly or only partially-related to myocardial iron deposition; or maybe MPI,
as the reduced S′ wave, reﬂects the persistence of previous iron related
damage on longitudinal ﬁbres despite normalization of T2* at MRI evalu-
ation. We should not forget that SQUID discovered a worsening in the
hepatic iron overload that could precede the heart iron overload. Anyway,
a pathological value of MPI should focus the attention on a TM patient
history and actual therapy, irrespective of T2* time.
Finally, we reported an increase in estimated pulmonary artery sys-
tolic pressure over time. Today is we'll know how the development of
pulmonary hypertension could affect long-term prognosis in β-
thalassemia, but despite the fact that today the real prevalence seems
to be lower than in previous reports, regarding b5% of patients [24],
the underlying pathophysiology has not been completely understood.
Severalmechanisms have been proposed such as tissue hypoxia causing
endothelial dysfunction and a high-output state due to anaemia. Fur-
thermore, chronic hemolysis results in nitric oxide depletion that pro-
motes vasoconstriction and hypercoagulability [25]. Lastly, oxidativeoppler Imaging) with left ventricular myocardial performance index (MPI).
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cular remodelling and increased vascular resistance: endothelial dys-
function due to iron overload can cause an imbalance between
vasodilator and vasoconstrictor substances in the pulmonary vascular
endothelium, which induces smooth muscle cell proliferation, thereby
leading to increased vascular resistance [3]. In our population, even in
the presence of values of normal TRV at baseline and after 4 years of
follow-up, we demonstrated a tendency to a statistically signiﬁcant
worsening. Despite new evidence stress the importance to conﬁrm
echocardiographic diagnostic value with right heart catheterization
[24], this result puts the spotlight on the chronic nature of the iron-
related damage also in the lungs, and the necessity to evaluate not
only the estimated PAPs with regularly echocardiographic study, but
also to compare it with the previous examinations in order to recognize
as early as it is possible the sign of alarm before the appearance of clin-
ical cardiac disease.
5. Limitations of this study
Although the original investigation about MPI used Doppler trans-
valvular velocities, TDI has been adequately validated and permits to
study the index inside a single heartbeat. The increase in systolic PAP
is signiﬁcant but still within the normal range: because systolic PAP
measurement should hide many sources of error we could not be sure
of its worsening. Changes may reﬂect aging, although worsening
seems to be too fast in just 4 years. We are in a lack of control group.
The population is little and the following-up is short and the study is
neither designed nor powered to detect clinical differences over time.
However, enrolment of patients has still been continuing, and perhaps
more follow-up studies would help better understand what is happen-
ing with the population. The strain technique has not been mentioned
in this study becausewewould like to explore TDI andMPI potentiality,
but correlation of our results with strain value could help to enforce our
conclusions in the future studies. The strain technique is not widely dif-
fused, especially in poorer countries, and often they need ofﬂine evalu-
ations while MPI is faster to be checked during a normal echo
examination.
6. Conclusions
Based on the results of our study, the tissue Doppler S′wave and tis-
sue Doppler derived MPI may be a simple and sensitive tools for the as-
sessment of LV function. They are easy to get during a normal
echocardiographic evaluation and it does not signiﬁcantly prolong the
examination time. Together with PAPs value they should be checked
in every TM patient looking for worsening at follow-up.
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